Education
About Us
Working with TipRanks
Follow Us
Baudax Bio (BXRXQ)
OTHER OTC:BXRXQ
Total Valuation
Baudax Bio has a market cap or net worth of $44.00. The enterprise value is ―.
Market Cap$44.00
Enterprise Value―
Share Statistics
Baudax Bio has 43,593,082 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding43,593,082
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Baudax Bio’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee141.00K
Profits Per Employee-6.53M
Employee Count9
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Baudax Bio is ―. Baudax Bio’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow>-0.01
PEG Ratio0.00
Income Statement
In the last 12 months, Baudax Bio had revenue of 1.27M and earned -58.80M in profits. Earnings per share was -177.30.
Revenue1.27M
Gross Profit-5.74M
Operating Income-56.81M
Pretax Income-58.80M
Net Income-58.80M
EBITDA-33.58M
Earnings Per Share (EPS)-177.30
Cash Flow
In the last 12 months, operating cash flow was -14.31M and capital expenditures -21.00K, giving a free cash flow of -14.33M billion.
Operating Cash Flow-14.31M
Free Cash Flow-14.33M
Free Cash Flow per Share-0.33
Dividends & Yields
Baudax Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-180.15
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Baudax Bio upcoming earnings date is Aug 13, 2024, After Close (Confirmed).
Last Earnings DateMay 2, 2024
Next Earnings DateAug 13, 2024
Ex-Dividend Date―
Financial Position
Baudax Bio as a current ratio of ―, with Debt / Equity ratio of -29.37%
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Baudax Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate―
Enterprise Valuation
Baudax Bio EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Baudax Bio has $363.00K in cash and marketable securities with $8.10M in debt, giving a net cash position of -$7.73M billion.
Cash & Marketable Securities$363.00K
Total Debt$8.10M
Net Cash-$7.73M
Net Cash Per Share-$0.18
Tangible Book Value Per Share―
Margins
Gross margin is -452.32%, with operating margin of ―, and net profit margin of ―.
Gross Margin-452.32%
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Baudax Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―